MPO positive (MPO+ve) B-ALL and MPO-negative (MOP-ve) B-ALL are further compared as regards the clinical features, routine laboratory parameters, FCM immunophenotyping (IPT) results, Philadelphia chromosome cytogenetic abnormality status and clinical outcomes measured by response to therapy, occurrence of relapse and overall survival (OS). Here, MPO is linked to acute lymphoblastic leukemia.